What do analysts expect the price target to be for CVRX INC (CVRX)?
13 analysts have analysed CVRX and the average price target is 11.99 USD. This implies a price increase of 60.23% is expected in the next year compared to the current price of 7.48.
NASDAQ:CVRX • US1266381052
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CVRX INC (CVRX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-02-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-09 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-05-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-08 | Lake Street | Maintains | Buy -> Buy |
| 2025-04-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-17 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-01-14 | William Blair | Upgrade | Market Perform -> Outperform |
| 2024-12-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-04 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-10-30 | Lake Street | Maintains | Buy -> Buy |
| 2024-10-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-30 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-10-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-08-26 | Lake Street | Reiterate | Buy -> Buy |
| 2024-07-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-11 | Lake Street | Maintains | Buy -> Buy |
| 2024-07-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 39.295M 74.88% | 51.292M 30.53% | 56.651M 10.45% | 66.377M 17.17% | 78.119M 17.69% | 97.165M 24.38% | 122.6M 26.18% | 135.66M 10.65% | |
| EBITDA YoY % growth | -42.581M -1.09% | -58.871M -38.26% | -50.509M 14.20% | -46.616M 7.71% | -43.339M 7.03% | -38.57M 11.00% | N/A | N/A | |
| EBIT YoY % growth | -43.103M -1.35% | -59.49M -38.02% | -51.265M 13.83% | -51.388M -0.24% | -45.315M 11.82% | -40.495M 10.64% | -33.252M 17.89% | -29.274M 11.96% | |
| Operating Margin | -109.69% | -115.98% | -90.49% | -77.42% | -58.01% | -41.68% | -27.12% | -21.58% | |
| EPS YoY % growth | -1.98 1.98% | -2.69 -35.86% | -2.05 23.79% | -2.05 0.06% | -1.81 11.52% | -1.71 5.89% | -1.40 18.09% | -1.22 12.41% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.51 2.95% | -0.53 6.95% | -0.49 -0.78% | -0.49 -5.48% | -0.51 1.35% | -0.49 7.98% | -0.45 8.60% | -0.44 10.13% | -0.55 -8.54% | -0.50 -2.40% | -0.47 -3.95% | -0.41 6.43% |
| Revenue Q2Q % growth | 14.684M 18.92% | 16.018M 17.87% | 17.237M 17.34% | 18.469M 15.26% | 17.302M 17.83% | 18.967M 18.41% | 20.749M 20.37% | 22.139M 19.87% | 22.848M 32.05% | 24.684M 30.14% | 26.622M 28.30% | 29.478M 33.15% |
| EBITDA Q2Q % growth | -11.301M 14.73% | -11.907M 14.94% | -11.328M 3.16% | -11.111M -6.55% | -10.968M 2.94% | -10.893M 8.52% | -10.591M 6.51% | -10.315M 7.17% | -11.322M -3.23% | -9.996M 8.24% | -8.976M 15.25% | -7.446M 27.81% |
| EBIT Q2Q % growth | -12.513M 6.88% | -13.274M 7.66% | -12.599M -2.70% | -12.37M -10.60% | -12.647M -1.07% | -12.529M 5.62% | -11.613M 7.83% | -11.327M 8.43% | -11.526M 8.86% | -10.2M 18.59% | -9.18M 20.95% | -7.65M 32.46% |
All data in USD
13 analysts have analysed CVRX and the average price target is 11.99 USD. This implies a price increase of 60.23% is expected in the next year compared to the current price of 7.48.
CVRX INC (CVRX) will report earnings on 2026-04-29, after the market close.
The consensus EPS estimate for the next earnings of CVRX INC (CVRX) is -0.51 USD and the consensus revenue estimate is 14.68M USD.
The expected long term growth rate for CVRX INC (CVRX) is 19.14%.